![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Farchemia S.r.l. Treviglio It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Carbamazepine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1997-119 - Rev 02
This Chemical Type CEP, issued on February 22, 2008, remains in force until December 10, 2009, ensuring its reliability within the pharmaceutical industry.
Substance Number 543 associated with this CEP further emphasizes